Sawgrass Asset Management’s Emergent Biosolutions EBS Stock Holding History

Sawgrass Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,061	Closed	-$420K	–	170
2020 Q3	$420K	Sell	4,061 -1,218	-23%	-$131K	0.03%	112
2020 Q2	$417K	Sell	5,279 -1,445	-21%	-$108K	0.03%	107
2020 Q1	$389K	Buy	+6,724	New	+$387K	0.03%	106
2019 Q2	–	Sell	-14,645	Closed	-$740K	–	181
2019 Q1	$740K	Sell	14,645 -18,560	-56%	-$1.09M	0.03%	128
2018 Q4	$1.97M	Buy	33,205 +7,965	+32%	+$513K	0.1%	75
2018 Q3	$1.66M	Buy	25,240 +6,245	+33%	+$364K	0.07%	102
2018 Q2	$959K	Sell	18,995 -34,650	-65%	-$1.81M	0.04%	131
2018 Q1	$2.82M	Buy	53,645 +30,655	+133%	+$1.53M	0.14%	65
2017 Q4	$1.07M	Buy	+22,990	New	+$968K	0.05%	123
2016 Q3	–	Sell	-19,870	Closed	-$559K	–	164
2016 Q2	$559K	Sell	19,870 -20,740	-51%	-$813K	0.03%	116
2016 Q1	$1.48M	Buy	+40,610	New	+$1.43M	0.07%	77

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sawgrass Asset Management's EBS Position: Q4 2020 in Review

Sawgrass Asset Management sold out of Emergent Biosolutions (EBS) in Q4 2020, closing a stake of 4,061 shares — an estimated $420K sold.

Sawgrass Asset Management first reported a position in EBS in Q1 2016 and held it in 11 quarters. The position peaked at $2.82M in Q1 2018. 353 funds tracked by Wall St. Rank hold EBS as of Q4 2020.

Sawgrass Asset Management reported no remaining Emergent Biosolutions position as of Q4 2020 after selling out during the quarter.
Sawgrass Asset Management sold 4,061 Emergent Biosolutions shares in Q4 2020, an estimated $420K.
Sawgrass Asset Management first reported a position in Emergent Biosolutions in Q1 2016 and held it in 11 quarters.
Sawgrass Asset Management's Emergent Biosolutions position peaked at $2.82M in Q1 2018.
353 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2020.

Based on Sawgrass Asset Management's 13F filing for Q4 2020, filed 22 Jan 2021.